Ratio Analysis & Valuation of Glaxo Smithkline Bangladesh Limited
Ratio Analysis & Valuation of Glaxo SmithKline Bangladesh Limited
Submitted To:
Suborna Barua Course Instructor School of Business, UIU
Submitted To:
Tanvir Ahmed Patwary ID: 111 092 142 Sec: B
Date of submission: 9th September, 2012
1 United International University
Overview of Pharmaceuticals Industry
The Pharmaceuticals Industry in Bangladesh is maintaining its momentum of strong double digit growth. In 2010, the market exceeded Taka 6 billion (US$ 900m) with a growth of about 15%. As in previous year, local companies lead the market place, occupying all top 10 positions in the market and leading the growth. The development of pharmaceuticals sector was accelerated after the promulgation of Drug Control Ordinance in 1982.The professional knowledge, thoughts and innovative ideas of the pharmaceutical professionals working in this sector are the major factors for these development. This pharmaceutical sector is also providing 97% of the total medicine requirement of the local market. At present some new industries have been established with high tech equipments and professionals that will enhance the strength of this sector.
Company Profile
Glaxo SmithKline(GSK) Bangladesh Limited carries with it an enviable image and reputation for the past 6 decades. A subsidiary of GlaxoSmithKline plc- one of the world’s leading research-based pharmaceutical and healthcare companies, GSK
Bangladesh is committed to its global mission of improving the quality of human life by enabling people to do more, feel better and live longer. In 1949 the Company commenced its journey in Bangladesh with its corporate identity as Glaxo in Chittagong as an importer of products from the Glaxo Group Companies. It started spreading its spectrum from being an importer to a manufacturer by establishing its own manufacturing unit at Chittagong in 1967. In line with mergers and acquisition the identity changed from Glaxo to Glaxo Welcome Bangladesh Limited following the
Submitted To:
Suborna Barua Course Instructor School of Business, UIU
Submitted To:
Tanvir Ahmed Patwary ID: 111 092 142 Sec: B
Date of submission: 9th September, 2012
1 United International University
Overview of Pharmaceuticals Industry
The Pharmaceuticals Industry in Bangladesh is maintaining its momentum of strong double digit growth. In 2010, the market exceeded Taka 6 billion (US$ 900m) with a growth of about 15%. As in previous year, local companies lead the market place, occupying all top 10 positions in the market and leading the growth. The development of pharmaceuticals sector was accelerated after the promulgation of Drug Control Ordinance in 1982.The professional knowledge, thoughts and innovative ideas of the pharmaceutical professionals working in this sector are the major factors for these development. This pharmaceutical sector is also providing 97% of the total medicine requirement of the local market. At present some new industries have been established with high tech equipments and professionals that will enhance the strength of this sector.
Company Profile
Glaxo SmithKline(GSK) Bangladesh Limited carries with it an enviable image and reputation for the past 6 decades. A subsidiary of GlaxoSmithKline plc- one of the world’s leading research-based pharmaceutical and healthcare companies, GSK
Bangladesh is committed to its global mission of improving the quality of human life by enabling people to do more, feel better and live longer. In 1949 the Company commenced its journey in Bangladesh with its corporate identity as Glaxo in Chittagong as an importer of products from the Glaxo Group Companies. It started spreading its spectrum from being an importer to a manufacturer by establishing its own manufacturing unit at Chittagong in 1967. In line with mergers and acquisition the identity changed from Glaxo to Glaxo Welcome Bangladesh Limited following the